Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Oxaliplatin-related neurotoxicity: is chelation the solution?

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout


  1. Andre T et al. (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350: 2343–2351

    Article  CAS  Google Scholar 

  2. Extra JM et al. (1990) Phase I study of oxaliplatin in patients with advanced cancer. Cancer Chemother Pharmacol 25: 299–303

    Article  CAS  Google Scholar 

  3. Gamelin E et al. (2002) Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures. Semin Oncol 29: 21–33

    Article  CAS  Google Scholar 

  4. De Gramont A et al. (2004) OPTIMOX study: FOLFOX 7/LV5FU2 compared to FOLFOX 4 in patients with advanced colorectal cancer [abstract]. Proc Am Soc Clin Oncol 23: a3525

    Article  Google Scholar 

Download references


The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Paulo M Hoff.

Ethics declarations

Competing interests

Dr Hoff has received a research grant from Sanofi-Synthelabo Inc.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hoff, P. Oxaliplatin-related neurotoxicity: is chelation the solution?. Nat Rev Clin Oncol 1, 78–79 (2004).

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing